DNDi and Cipla advance development of pediatric 4-in-1 ARVs to fulfill new WHO guidelines

... HIV guidelines, Dr Jaideep A Gogtay, Chief Medical Officer of Cipla, said, 'Cipla reinforces its commitment towards HIV/AIDS and will continue to develop novel and child-friendly formulations to ensure wider access of ARV drugs to HIV-infected ...

http://www.eurekalert.org/pub_releases/2013-06/dfnd-dc062613.php